Zalicus to Present at BIO CEO & Investor Conference

6 February 2012, 1:01 pm

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced that Mark H.N.... Read More »

More Topics from "Articles"

• Hilton Worldwide Re-Brands the Elysian as the Waldorf Astoria Chicago
• PolyMedix to Present at the 14th Annual BIO CEO and Investor Conference
• Cytokinetics to Present at BIO CEO and Investor Conference
• Targacept Announces Participation in Upcoming Conferences
• Quinn to Christie: Stop “Playing Games” With Marriage
• Global AgInvesting(SM) Welcomes Jim Rogers, Internationally-Renowned Economist, As Keynote Speaker
• Ticket Summit(R) Draws Top Executives in Live Entertainment
• Global AgInvesting(SM) Promises to be the Most Critical Agricultural Investing Conference in 2012
• Tommy Moloney's, the Largest Provider of Irish Food Products in U.S., in Major Irish Food Promotion in New York